Transdermal scopolamine-induced neurologic deficits in patients with cancer.
Friedberg
M H
MH
Department of Clinical Neurosciences, Brown University School of Medicine, Providence, Rhode Island.
Glantz
M J
MJ
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D009325:Nausea / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications*; D009422:Nervous System Diseases / Q000139:chemically induced*; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D012601:Scopolamine